The multifaceted value of antidepressants in cancer therapeutics

European Journal of Cancer

Volumn 44, Issue 2, 2008, Pages 172-174

  Lieb, Julian ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; CLORGYLINE; FLUOXETINE; IMIPRAMINE; INDOMETACIN; LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PHENELZINE; PROCARBAZINE; PROSTAGLANDIN; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CANCER THERAPY; CARCINOGENESIS; CELL PROTECTION; CELLULAR IMMUNITY; CHEMOTHERAPY INDUCED EMESIS; COLON CANCER; DEPRESSION; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNITY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; TUBERCULOSIS;

EID: 38349014618     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.11.006     Document Type: Note

References (36)

1. Fitzpatrick F.A. Cyclooxygenase enzymes: regulation and function. Curr Pharm Des 10 6 (2004) 577-588
2. Horrobin D.F., and Manku M.S. Roles of prostaglandins suggested by the prostaglandin agonist/antagonist actions of local anesthetic, anti-arrhythmic, anti-malarial, tricyclic anti-depressant and methyl xanthine compounds. Effects on membranes and on nucleic acid function. Med Hypotheses 3 2 (1977) 71-86
3. Hughes-Fulford M. Prostaglandin regulation of gene expression and growth in normal and malignant tissues. Adv Exp Med Biol 400 A (1997) 269-278
4. Armato U., and Andreis P.G. Prostaglandins of the F series are extremely powerful growth factors for primary neonatal rat hepatocytes. Life Sci 33 (1983) 1745-1755
5. Goodlad R.A., Madgwick A.J., Moffatt M.R., et al. Prostaglandins and the dog stomach: effects of misoprostol on the proportion of mucosa to muscle and on the proportion of different epithelial type cells. Digestion 45 (1990) 212-216
6. Lieb J. Antidepressants, prostaglandins and the prevention and treatment of cancer. Med Hypotheses 69 (2007) 684-689
7. Lieb J. Antidepressants, eicosanoids and the prevention and treatment of cancer. Plefa 65 5-6 (2001) 233-239
8. Williams E.D., Karim S.M.M., and Sandler M. Prostaglandin secretion by medullary carcinoma of the thyroid. Lancet 1 (1968) 22-23
9. Goodwin J.S., Murphy S., Bankhurst A.D., et al. Prostaglandin-producing suppressor cells in Hodgkin's disease. New Engl J Med 297 (1977) 963-968
10. Pace E., Siena L., Ferraro M., et al. Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis. Eur J Cancer 42 14 (2006) 236-239 [Epub 2006 Aug 8]
11. Molina M.A., Sitja-Arnau M., Lemoine M.G., Frazier M.L., and Sinicrope F.A. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by non-steroidal anti-inflammatory drugs. Cancer Res 59 17 (1999) 4356-4362 17 (2): 179-191
12. Thun M.J., Namboordiri M.M., and Heath Jr. C.W. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325 (1991) 1593-1956
13. Lieb J. The immunostimulating and antimicrobial properties of lithium and antidepressants. J Infection 49 2 (2004) 88-93
14. Lieb J. Lithium and antidepressants: stimulating immune function and preventing and reversing infection. Med Hypotheses 69 (2007) 8-11
15. Bankhurst A. The modulation of human natural killer cell activity by prostaglandins. J Clin Lab Immunol 7 (1982) 8591
16. Ballin A., Gershon V., Brener J., Weizman A., and Meytes D. The antidepressant fluvoxamine increases natural killer cell counts in cancer patients. Isr J Med Sci 33 11 (1997) 720-723
17. Frank M., Hendricks S., Johnson D., et al. Antidepressants augments natural killer cell activity: in vivo and in vitro. Neuropsychobiology 39 1 (1999) 18-24
18. Horton E.W. Actions of prostaglandins E1, E2 and E3 on the central nervous system. Brit J Pharmacol 22 (1964) 189-192
19. Horrobin D., Mtabaji J., Manku M., et al. Lithium as a regulator of hormone-stimulated prostaglandin synthesis. Lithium in medical practice (1978), University Park Press, Baltimore p. 243-63
20. Lee R. The influence of psychotropic drugs on prostaglandin biosynthesis. Prostaglandins 5 1 (1974) 63-68
21. Horrobin D.F., Manku M., and Mtabaji J. A new mechanism of tricyclic antidepressant action. Blockade of prostaglandin-dependent calcium movements. Postgraduate Med J 53 Suppl.4 (1977) 19-23
22. Mtabaji J.P., Manku M.S., and Horrobin D.F. Actions of the tricyclic antidepressant clomipramine on responses to pressor agents: interactions with prostaglandin E2. Prostaglandins 14 (1977) 125-132
23. Yaron I., Shirazi I., Judovich R., et al. Arthritis Rheum 42 12 (1999) 2561-2568
24. Penninx B.W., Guralnik J.M., Pahor M., et al. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90 24 (1998) 1888-1893
25. Levkovitz Y., Gil-Ad I., Zeidich E., et al. Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 27 1 (2005) 29-42
26. Arimochi H., and Morita K. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 541 1-2 (2006) 17-23
27. Volpe D.A., Ellison C.D., Parchment R.E., Grieshaber C.K., and Faustino P.J. Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines. J Exp Ther Oncol 3 4 (2003) 169-184
28. Peer D., and Margalit R. Fluoxetine and reversal of multidrug resistance. Cancer Lett 237 2 (2006) 180-187
29. Yan M., Rerko R.M., Platzer P., et al. 15-Hydroxyprostaglandin dehydrogenase, a Cox-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci USA 101 50 (2004) 17468-17473 [Epub 2004 Dec 1]
30. Mak O., and Chen S. Effects of two antidepressant drugs imipramine and amitriptyline on the enzyme activity of 15-hydroxyprostaglandin dehydrogenase purified from brain, lung, liver and kidney of mouse. Prog Lipid Res 25 (1986) 153-155
31. Durand J.P., Brezault C., and Goldwasser F. Protection against oxaliplatin acute neurosensory toxicity by venlafaxine. Anticancer Drugs i14 6 (2003) 423-425
32. Seymour C.B., Mothersill C., Mooney R., Moriarty M., and Tipton K.F. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionizing radiation and chemotherapy toxicity. Br J Cancer 89 10 (2003) 1979-1986
33. Khouzam H.R., Monteiro A.J., and Gerken M.E. Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefadazone. Psychosom Med (1998) 60
34. Lieb J., and Balter A. Antidepressant tachyphylaxis. Med Hypotheses 15 (1984) 279-291
35. Wallace W.A., Baltsitis M., and Harrison B.J. Male breast neoplasia in association with selective serotonin reuptake inhibitor therapy: a report of three cases. Eur J Surg Oncol 27 4 (2001) 429-431
36. Serebruany V.L., Glasssman A.H., Malinin A.I., et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the sertraline antidepressant heart attack randomized trial (SADHART) platelet substudy. Circulation 108 8 (2003) 939-944 [Epub 2003 Aug 11]